Clinical Trials Directory

Trials / Completed

CompletedNCT03338907

CO2 (Carbon Dioxide) - Cerebral Oxygenation

Anesthesia vs Aviation: Does Added Carbon Dioxide in Normobaric Hypoxia Have the Same Effect on Cerebral Oxygenation as in Hypobaric Hypoxia?

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Several projects in high altitude research in environments with a low oxygen partial pressure (hypobaric hypoxia) leading to hypoxemia showed, that cerebral perfusion and cerebral performance could be improved by adding C02 (cabon dioxide). The investigators hypothesize that adding 5% C02 to 02 (Oxygen) also under normobaric conditions increases the time until a significant cerebral hyopxia is measured by near infrared spectroscopy (NIRS) compared to the administration of 95% 02. lf this hypothesis proves to be true, this approach might be used in situations in which individuals are prone to cerebral hypoxia. In bariatric surgery, patients that experience an apnea phase are more prone to (cerebral) hypoxia due to the fact, that they have a higher body mass index (BMI) leading to a reduced functional residual capacity (FRC), which serves as the oxygen reserve in the body.

Detailed description

On the day of surgery patients will be randomized. After induction of anesthesia and endotracheal intubation patients will be managed by the study team to perform the intervention and the measurements. According to randomization, investigational medical product (IMP) or comparator will be administrated by ventilator 1/ventilator 2. At time point 1 apnea will be performed by disconnecting the ventilator from the endotracheal tube until the NIRS value has dropped by 20% from baseline. After that, re-ventilation will be resumed immediately, until parameters have returned to baseline. During apnea time NIRS and vital signs will be recorded permanently, blood samples will be drawn at definite time points. Application of IMP (or comparator) will be performed in this cross-over study design in the same manner after the baseline level is reached again. At the end of the study procedure, after the baseline level of end-expiratory CO2 is reached again, patient will be taken over by the clinical anesthesia team and surgeons.

Conditions

Interventions

TypeNameDescription
DRUGOxycarbon (5% CO2+ 95% O2)Oxycarbon will be administered by mechanical ventilation

Timeline

Start date
2018-01-25
Primary completion
2018-10-26
Completion
2019-02-12
First posted
2017-11-09
Last updated
2019-02-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03338907. Inclusion in this directory is not an endorsement.